Oakbrook Investments’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,150
Closed -$402K 559
2019
Q4
$402K Hold
6,150
0.08% 387
2019
Q3
$486K Hold
6,150
0.03% 388
2019
Q2
$355K Buy
6,150
+300
+5% +$17.6K 0.02% 456
2019
Q1
$307K Buy
5,850
+300
+5% +$15.7K 0.02% 494
2018
Q4
$293K Sell
5,550
-900
-14% -$51.4K 0.02% 479
2018
Q3
$409K Buy
6,450
+1,900
+42% +$123K 0.02% 484
2018
Q2
$266K Sell
4,550
-690
-13% -$37.4K 0.02% 485
2018
Q1
$268K Buy
5,240
+560
+12% +$30K 0.02% 497
2017
Q4
$279K Buy
4,680
+580
+14% +$35.2K 0.02% 483
2017
Q3
$242K Buy
+4,100
New +$244K 0.02% 510

Other funds holding CONE

Oakbrook Investments's CONE Position: Q1 2020 in Review

Oakbrook Investments sold out of CyrusOne Inc Common Stock (CONE) in Q1 2020, closing a stake of 6,150 shares — an estimated $402K sold.

Oakbrook Investments first reported a position in CONE in Q3 2017 and held it in 10 quarters. The position peaked at $486K in Q3 2019. 414 funds tracked by Wall St. Rank hold CONE as of Q1 2020.

  • Oakbrook Investments reported no remaining CyrusOne Inc Common Stock position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 6,150 CyrusOne Inc Common Stock shares in Q1 2020, an estimated $402K.
  • Oakbrook Investments first reported a position in CyrusOne Inc Common Stock in Q3 2017 and held it in 10 quarters.
  • Oakbrook Investments's CyrusOne Inc Common Stock position peaked at $486K in Q3 2019.
  • 414 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.